Products billed under this code include Levalbuterol Inhalation Solution Concentrated.
Payment limit per 0.5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Levalbuterol Inhalation Solution Concentrated | Mylan Pharmaceuticals Inc. | 00378-6993-93 | 75 | $22.80 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.304 | −$0.039 | 0.5 MG | Levalbuterol non-comp con | v1, posted September 17, 2026 |
| 3Q26 | $0.343 | +$0.024 | 0.5 MG | Levalbuterol non-comp con | v1, posted September 15, 2026 |
| 2Q26 | $0.319 | −$0.065 | 0.5 MG | Levalbuterol non-comp con | v1, posted September 15, 2026 |
| 1Q26 | $0.384 | +$0.11 | 0.5 MG | Levalbuterol non-comp con | v1, posted September 15, 2026 |
| 4Q25 | $0.274 | −$0.026 | 0.5 MG | Levalbuterol non-comp con | v1, posted September 8, 2026 |
| 3Q25 | $0.30 | +$0.017 | 0.5 MG | Levalbuterol non-comp con | v1, posted March 10, 2026 |
| 2Q25 | $0.283 | −$0.011 | 0.5 MG | Levalbuterol non-comp con | v1, posted March 10, 2026 |
| 1Q25 | $0.294 | +$0.061 | 0.5 MG | Levalbuterol non-comp con | v1, posted December 19, 2025 |
| 4Q24 | $0.233 | −$0.038 | 0.5 MG | Levalbuterol non-comp con | v1, posted June 11, 2025 |
| 3Q24 | $0.271 | +$0.038 | 0.5 MG | Levalbuterol non-comp con | v1, posted June 11, 2025 |
| 2Q24 | $0.233 | −$0.075 | 0.5 MG | Levalbuterol non-comp con | v1, posted March 11, 2025 |
| 1Q24 | $0.308 | +$0.083 | 0.5 MG | Levalbuterol non-comp con | v1, posted December 19, 2024 |
| 4Q23 | $0.225 | −$0.029 | 0.5 MG | Levalbuterol non-comp con | v1, posted October 10, 2024 |
| 3Q23 | $0.254 | −$0.019 | 0.5 MG | Levalbuterol non-comp con | v1, posted June 5, 2024 |
| 2Q23 | $0.273 | +$0.045 | 0.5 MG | Levalbuterol non-comp con | v1, posted February 23, 2024 |
| 1Q23 | $0.228 | −$0.073 | 0.5 MG | Levalbuterol non-comp con | v1, posted December 6, 2023 |
| 4Q22 | $0.301 | +$0.034 | 0.5 MG | Levalbuterol non-comp con | v1, posted June 22, 2023 |
| 3Q22 | $0.267 | −$0.002 | 0.5 MG | Levalbuterol non-comp con | v1, posted June 9, 2023 |
| 2Q22 | $0.269 | −$0.02 | 0.5 MG | Levalbuterol non-comp con | v1, posted December 14, 2022 |
| 1Q22 | $0.289 | −$0.001 | 0.5 MG | Levalbuterol non-comp con | v1, posted June 8, 2022 |
| 4Q21 | $0.29 | −$0.004 | 0.5 MG | Levalbuterol non-comp con | v1, posted June 2, 2022 |
| 3Q21 | $0.294 | −$0.036 | 0.5 MG | Levalbuterol non-comp con | v1, posted June 2, 2022 |
| 2Q21 | $0.33 | +$0.033 | 0.5 MG | Levalbuterol non-comp con | v1, posted March 1, 2022 |
| 1Q21 | $0.297 | – | 0.5 MG | Levalbuterol non-comp con | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
